Chronic kidney disease (CKD) is a worldwide public health problem. Patients in advanced stages of CKD consume an enormous portion of healthcare resources, with signi?cantly high mortality and morbidity and a reduced quality of life. Currently glomerular ?ltration rate (GFR) is the most used index to assess kidney function and urinary albumin excretion (UAC) is the earlier marker of kidney damage and predictor of progression of CKD. In this regard, an extensive diversity of studies has been done in order to investigate biomarkers that link renal damage with associated diseases such as hypertension, diabetes, cardiovascular diseases and others.
In this Research Topic in Frontiers in Nephrology, we would like to publish original papers or reviews about biomarkers, ranging from urinary to serum markers, that could lead to a better understanding of the development and progression of CKD associated with other detection of kidney injury in early diseases and/or promising earlier markers for the stages of CKD.
Chronic kidney disease (CKD) is a worldwide public health problem. Patients in advanced stages of CKD consume an enormous portion of healthcare resources, with signi?cantly high mortality and morbidity and a reduced quality of life. Currently glomerular ?ltration rate (GFR) is the most used index to assess kidney function and urinary albumin excretion (UAC) is the earlier marker of kidney damage and predictor of progression of CKD. In this regard, an extensive diversity of studies has been done in order to investigate biomarkers that link renal damage with associated diseases such as hypertension, diabetes, cardiovascular diseases and others.
In this Research Topic in Frontiers in Nephrology, we would like to publish original papers or reviews about biomarkers, ranging from urinary to serum markers, that could lead to a better understanding of the development and progression of CKD associated with other detection of kidney injury in early diseases and/or promising earlier markers for the stages of CKD.